vs
Organogenesis Holdings Inc.(ORGO)与Purple Innovation, Inc.(PRPL)财务数据对比。点击上方公司名可切换其他公司
Purple Innovation, Inc.的季度营收约是Organogenesis Holdings Inc.的3.8倍($140.7M vs $37.2M),Purple Innovation, Inc.同比增速更快(9.1% vs -57.1%),过去两年Purple Innovation, Inc.的营收复合增速更高(8.3% vs -46.5%)
Organogenesis Holdings Inc.是一家领先的再生医学企业,专注于开发、生产用于伤口护理、外科修复、运动医学和皮肤病领域的先进治疗产品,主要服务美国及部分国际市场的医疗机构与患者,提供经临床验证的医疗解决方案。
Purple Carrot是一家总部位于马萨诸塞州尼达姆市的全植物性餐包品牌,由安迪·莱维特创立,每周为订阅用户提供预制餐品和自制餐包。据《大都会》2022年报道,对比美式标准餐食,该品牌每份餐包的碳排放量可降低72%,主打低碳环保的纯植物饮食方案。
ORGO vs PRPL — 直观对比
营收规模更大
PRPL
是对方的3.8倍
$37.2M
营收增速更快
PRPL
高出66.1%
-57.1%
两年增速更快
PRPL
近两年复合增速
-46.5%
损益表 — Q1 FY2026 vs Q4 FY2025
| 指标 | ||
|---|---|---|
| 营收 | $37.2M | $140.7M |
| 净利润 | — | $-3.2M |
| 毛利率 | 30.8% | 41.9% |
| 营业利润率 | -185.1% | -1.6% |
| 净利率 | — | -2.3% |
| 营收同比 | -57.1% | 9.1% |
| 净利润同比 | — | 62.1% |
| 每股收益(稀释后) | — | $0.03 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比,按日历期对齐,财年错位的公司也能正确匹配
营收
ORGO
PRPL
| Q1 26 | $37.2M | — | ||
| Q4 25 | $225.6M | $140.7M | ||
| Q3 25 | $150.9M | $118.8M | ||
| Q2 25 | $101.0M | $105.1M | ||
| Q1 25 | $86.7M | $104.2M | ||
| Q4 24 | $126.7M | $129.0M | ||
| Q3 24 | $115.2M | $118.6M | ||
| Q2 24 | $130.2M | $120.3M |
净利润
ORGO
PRPL
| Q1 26 | — | — | ||
| Q4 25 | $43.7M | $-3.2M | ||
| Q3 25 | $21.6M | $-11.7M | ||
| Q2 25 | $-9.4M | $-17.3M | ||
| Q1 25 | $-18.8M | $-19.1M | ||
| Q4 24 | $7.7M | $-8.5M | ||
| Q3 24 | $12.3M | $-39.2M | ||
| Q2 24 | $-17.0M | $27.0K |
毛利率
ORGO
PRPL
| Q1 26 | 30.8% | — | ||
| Q4 25 | — | 41.9% | ||
| Q3 25 | — | 42.8% | ||
| Q2 25 | — | 35.9% | ||
| Q1 25 | 72.6% | 39.4% | ||
| Q4 24 | 75.5% | 42.9% | ||
| Q3 24 | 76.7% | 29.7% | ||
| Q2 24 | 77.6% | 40.7% |
营业利润率
ORGO
PRPL
| Q1 26 | -185.1% | — | ||
| Q4 25 | 28.1% | -1.6% | ||
| Q3 25 | 13.7% | -10.2% | ||
| Q2 25 | -12.5% | -13.5% | ||
| Q1 25 | -30.9% | -13.9% | ||
| Q4 24 | 8.1% | -6.0% | ||
| Q3 24 | 5.4% | -39.5% | ||
| Q2 24 | -10.7% | -12.1% |
净利率
ORGO
PRPL
| Q1 26 | — | — | ||
| Q4 25 | 19.4% | -2.3% | ||
| Q3 25 | 14.3% | -9.9% | ||
| Q2 25 | -9.3% | -16.5% | ||
| Q1 25 | -21.7% | -18.4% | ||
| Q4 24 | 6.1% | -6.6% | ||
| Q3 24 | 10.7% | -33.1% | ||
| Q2 24 | -13.1% | 0.0% |
每股收益(稀释后)
ORGO
PRPL
| Q1 26 | — | — | ||
| Q4 25 | $0.31 | $0.03 | ||
| Q3 25 | $0.11 | $0.11 | ||
| Q2 25 | $-0.10 | $0.16 | ||
| Q1 25 | $-0.17 | $0.18 | ||
| Q4 24 | $0.05 | $0.08 | ||
| Q3 24 | $0.09 | $0.36 | ||
| Q2 24 | $-0.13 | $0.00 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | ||
|---|---|---|
| 现金及短期投资手头流动性 | $91.4M | $24.3M |
| 总债务越低越好 | — | $126.7M |
| 股东权益账面价值 | — | $-29.7M |
| 总资产 | $520.0M | $296.3M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势,按日历期对齐
现金及短期投资
ORGO
PRPL
| Q1 26 | $91.4M | — | ||
| Q4 25 | $93.7M | $24.3M | ||
| Q3 25 | $63.7M | $32.4M | ||
| Q2 25 | $73.1M | $34.2M | ||
| Q1 25 | $110.0M | $21.6M | ||
| Q4 24 | $135.6M | $29.0M | ||
| Q3 24 | $94.3M | $23.4M | ||
| Q2 24 | $89.9M | $23.4M |
总债务
ORGO
PRPL
| Q1 26 | — | — | ||
| Q4 25 | — | $126.7M | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | $70.7M | ||
| Q3 24 | $62.3M | $50.8M | ||
| Q2 24 | $63.8M | — |
股东权益
ORGO
PRPL
| Q1 26 | — | — | ||
| Q4 25 | $300.1M | $-29.7M | ||
| Q3 25 | $255.1M | $-26.9M | ||
| Q2 25 | $233.2M | $-15.6M | ||
| Q1 25 | $242.9M | $1.3M | ||
| Q4 24 | $262.9M | $20.2M | ||
| Q3 24 | $278.5M | $28.0M | ||
| Q2 24 | $263.5M | $66.4M |
总资产
ORGO
PRPL
| Q1 26 | $520.0M | — | ||
| Q4 25 | $598.7M | $296.3M | ||
| Q3 25 | $509.8M | $302.1M | ||
| Q2 25 | $461.1M | $303.8M | ||
| Q1 25 | $467.4M | $293.8M | ||
| Q4 24 | $497.9M | $307.8M | ||
| Q3 24 | $446.3M | $309.3M | ||
| Q2 24 | $443.2M | $362.1M |
负债/权益比
ORGO
PRPL
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 3.50× | ||
| Q3 24 | 0.22× | 1.82× | ||
| Q2 24 | 0.24× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | ||
|---|---|---|
| 经营现金流最新季度 | — | $-5.8M |
| 自由现金流经营现金流 - 资本支出 | — | $-7.8M |
| 自由现金流率自由现金流/营收 | — | -5.5% |
| 资本支出强度资本支出/营收 | — | 1.4% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | — | $-41.9M |
8季度趋势,按日历期对齐
经营现金流
ORGO
PRPL
| Q1 26 | — | — | ||
| Q4 25 | $39.4M | $-5.8M | ||
| Q3 25 | $3.1M | $-968.0K | ||
| Q2 25 | $-32.9M | $-4.0M | ||
| Q1 25 | $-19.9M | $-23.1M | ||
| Q4 24 | $10.9M | $6.8M | ||
| Q3 24 | $8.7M | $1.1M | ||
| Q2 24 | $4.7M | $-8.9M |
自由现金流
ORGO
PRPL
| Q1 26 | — | — | ||
| Q4 25 | $34.8M | $-7.8M | ||
| Q3 25 | $844.0K | $-1.8M | ||
| Q2 25 | $-36.5M | $-7.0M | ||
| Q1 25 | $-23.6M | $-25.3M | ||
| Q4 24 | $7.6M | $5.7M | ||
| Q3 24 | $6.1M | $101.0K | ||
| Q2 24 | $2.9M | $-11.0M |
自由现金流率
ORGO
PRPL
| Q1 26 | — | — | ||
| Q4 25 | 15.4% | -5.5% | ||
| Q3 25 | 0.6% | -1.5% | ||
| Q2 25 | -36.1% | -6.6% | ||
| Q1 25 | -27.2% | -24.3% | ||
| Q4 24 | 6.0% | 4.4% | ||
| Q3 24 | 5.3% | 0.1% | ||
| Q2 24 | 2.2% | -9.2% |
资本支出强度
ORGO
PRPL
| Q1 26 | — | — | ||
| Q4 25 | 2.1% | 1.4% | ||
| Q3 25 | 1.5% | 0.7% | ||
| Q2 25 | 3.6% | 2.8% | ||
| Q1 25 | 4.2% | 2.2% | ||
| Q4 24 | 2.7% | 0.8% | ||
| Q3 24 | 2.2% | 0.9% | ||
| Q2 24 | 1.4% | 1.7% |
现金转化率
ORGO
PRPL
| Q1 26 | — | — | ||
| Q4 25 | 0.90× | — | ||
| Q3 25 | 0.14× | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 1.43× | — | ||
| Q3 24 | 0.71× | — | ||
| Q2 24 | — | -330.22× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
ORGO
暂无分部数据
PRPL
| Cost Of Revenues | $81.7M | 58% |
| Other | $59.0M | 42% |